Monument Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Sell
12,267
-15,679
-56% -$2.07M 0.31% 92
2026
Q1
$3.89M Buy
27,946
+14,152
+103% +$1.98M 0.98% 37
2025
Q4
$1.69M Buy
13,794
+3,980
+41% +$484K 0.42% 79
2025
Q3
$1.09M Buy
9,814
+572
+6% +$65K 0.27% 91
2025
Q2
$1.02M Buy
9,242
+1,092
+13% +$116K 0.27% 92
2025
Q1
$913K Buy
8,150
+996
+14% +$103K 0.28% 89
2024
Q4
$661K Buy
7,154
+1,021
+17% +$91.9K 0.18% 97
2024
Q3
$514K Buy
6,133
+1,266
+26% +$96.6K 0.14% 114
2024
Q2
$334K Sell
4,867
-4,825
-50% -$322K 0.1% 135
2024
Q1
$710K Sell
9,692
-1,265
-12% -$97.3K 0.2% 98
2023
Q4
$888K Buy
10,957
+1,120
+11% +$87.2K 0.29% 85
2023
Q3
$737K Sell
9,837
-456
-4% -$35.1K 0.25% 87
2023
Q2
$793K Sell
10,293
-709
-6% -$56.5K 0.25% 79
2023
Q1
$913K Buy
11,002
+1,482
+16% +$123K 0.31% 74
2022
Q4
$817K Buy
9,520
+1,460
+18% +$116K 0.28% 82
2022
Q3
$497K Buy
+8,060
New +$508K 0.19% 96
2018
Q4
Sell
-1,100
Closed -$85K 186
2018
Q3
$85K Buy
+1,100
New +$83.1K 0.05% 109

Other funds holding GILD

Monument Capital Management's GILD Position: Q2 2026 in Review

Monument Capital Management reduced its Gilead Sciences (GILD) stake by 56% in Q2 2026, selling an estimated $2.07M and leaving 12,267 shares worth $1.55M. The position accounts for 0.31% of the portfolio, ranked #92.

Monument Capital Management first reported a position in GILD in Q3 2018 and has held it in 17 quarters since. The position peaked at $3.89M in Q1 2026. 1,031 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Monument Capital Management held 12,267 shares of Gilead Sciences worth $1.55M as of Q2 2026.
  • Monument Capital Management sold 15,679 Gilead Sciences shares in Q2 2026, an estimated $2.07M.
  • Gilead Sciences made up 0.31% of Monument Capital Management's portfolio in Q2 2026, its #92 holding.
  • Monument Capital Management first reported a position in Gilead Sciences in Q3 2018 and has held it in 17 quarters since.
  • Monument Capital Management's Gilead Sciences position peaked at $3.89M in Q1 2026.
  • 1,031 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Monument Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.